What is he best known for?
The fields of study he is best known for:
- Cancer
- Gene
- Internal medicine
His primary areas of investigation include Immunology, Antigen, Immune system, Cancer and CTL*.
His work carried out in the field of Immunology brings together such families of science as Cytotoxic T cell and Cancer research, Melanoma.
His Antigen research integrates issues from Antibody and NY-ESO-1.
His NY-ESO-1 study integrates concerns from other disciplines, such as Melanoma-Specific Antigens, Cancer/testis antigens and Clinical trial.
His work in the fields of Cancer, such as Immunotherapy, overlaps with other areas such as Valproic Acid.
His CTL* study combines topics in areas such as T lymphocyte, Monoclonal antibody and Cytolysis.
His most cited work include:
- A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma (3136 citations)
- Simultaneous Humoral and Cellular Immune Response against Cancer–Testis Antigen NY-ESO-1: Definition of Human Histocompatibility Leukocyte Antigen (HLA)-A2–binding Peptide Epitopes (692 citations)
- A Survey of the Humoral Immune Response of Cancer Patients to a Panel of Human Tumor Antigens (662 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Antigen, Immunology, Internal medicine, Cancer and Immune system.
His biological study spans a wide range of topics, including Cytotoxic T cell, Antibody and Molecular biology.
His research on Immunology frequently links to adjacent areas such as Cancer research.
His research in Internal medicine intersects with topics in Gastroenterology, Surgery and Oncology.
The study incorporates disciplines such as Melanoma, T lymphocyte and Human leukocyte antigen in addition to CTL*.
The Cancer/testis antigens study combines topics in areas such as Pathology and NY-ESO-1.
He most often published in these fields:
- Antigen (39.02%)
- Immunology (34.75%)
- Internal medicine (24.92%)
What were the highlights of his more recent work (between 2009-2021)?
- Immunology (34.75%)
- Cancer (22.95%)
- Antigen (39.02%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Immunology, Cancer, Antigen, Internal medicine and Immune system.
His Immunology study incorporates themes from Cytotoxic T cell and Cancer research.
As part of one scientific family, Alexander Knuth deals mainly with the area of Cancer, narrowing it down to issues related to the Melanoma, and often Metastasis.
His study in Antigen is interdisciplinary in nature, drawing from both Cancer/testis antigens, Cancer immunotherapy, Antibody, Monoclonal antibody and Radiation therapy.
His Internal medicine research includes themes of Gastroenterology, Surgery and Oncology.
Alexander Knuth has researched Immune system in several fields, including Epitope and Tramp.
Between 2009 and 2021, his most popular works were:
- Classification of current anticancer immunotherapies (249 citations)
- Radiotherapy Promotes Tumor-Specific Effector CD8+ T Cells via Dendritic Cell Activation (219 citations)
- Aldara activates TLR7-independent immune defence (167 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
Alexander Knuth focuses on Immunology, Immune system, Cancer, Antigen and CD8.
His Immunology research incorporates themes from Receptor, Biophysics and Signal transduction.
His work in the fields of Immune system, such as T cell and Tumor microenvironment, intersects with other areas such as Protamine and Nanoparticle.
His Cancer research incorporates elements of Immunohistochemistry, Pathology and Cancer research.
Alexander Knuth combines subjects such as Radiation therapy, Sarcoma and Cancer immunotherapy with his study of Antigen.
His work in CD8 addresses issues such as Cytotoxic T cell, which are connected to fields such as Dendritic cell and Cell biology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
